Anupam Rasayan India Ltd vs Rossari Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Anupam Rasayan India Ltd is ₹ 1251 as of 20 Mar 15:30 . The P/E Ratio of Anupam Rasayan India Ltd changed from 69.7 on March 2021 to 89.8 on March 2025 . This represents a CAGR of 5.20% over 5 yearsThe P/E Ratio of Rossari Biotech Ltd changed from 67.2 on March 2021 to 24.5 on March 2025 . This represents a CAGR of -18.27% over 5 years The Market Cap of Anupam Rasayan India Ltd changed from ₹ 4900 crore on March 2021 to ₹ 8382 crore on March 2025 . This represents a CAGR of 11.33% over 5 yearsThe Market Cap of Rossari Biotech Ltd changed from ₹ 5388 crore on March 2021 to ₹ 3344 crore on March 2025 . This represents a CAGR of -9.10% over 5 years The revenue of Anupam Rasayan India Ltd for the Dec '25 is ₹ 514.55 crore as compare to the Sep '25 revenue of ₹ 739.19 crore. This represent the decline of -30.39% The revenue of Rossari Biotech Ltd for the Dec '25 is ₹ 582.59 crore as compare to the Sep '25 revenue of ₹ 588.18 crore. This represent the decline of -0.95% The ebitda of Anupam Rasayan India Ltd for the Dec '25 is ₹ 129.58 crore as compare to the Sep '25 ebitda of ₹ 143.58 crore. This represent the decline of -9.75% The ebitda of Rossari Biotech Ltd for the Dec '25 is ₹ 69.78 crore as compare to the Sep '25 ebitda of ₹ 74 crore. This represent the decline of -5.7% The net profit of Anupam Rasayan India Ltd changed from ₹ 12.21 crore to ₹ 60.59 crore over 7 quarters. This represents a CAGR of 149.77% The net profit of Rossari Biotech Ltd changed from ₹ 34.9 crore to ₹ 32.77 crore over 7 quarters. This represents a CAGR of -3.53% The Dividend Payout of Anupam Rasayan India Ltd changed from 7.15 % on March 2021 to 11.35 % on March 2025 . This represents a CAGR of 9.68% over 5 yearsThe Dividend Payout of Rossari Biotech Ltd changed from 3.28 % on March 2021 to 2.41 % on March 2025 . This represents a CAGR of -5.98% over 5 years .

About Anupam Rasayan India Ltd

Anupam Rasayan India Limited was initially formed as a Partnership Firm as 'Anupam Rasayan' effective from April 01, 1984 at Surat in Gujarat.
The Partnership Firm was registered under the Indian Partnership Act, 1932 with Registrar of Firms, Surat in October 22, 1984. Subsequently, the Partnership Firm converted into a joint stock company and was registered as a Public Limited Company under the name 'Anupam Rasayan India Limited' dated September 30, 2003, issued by Registrar of Companies, Gujarat, Dadra and Nagar Haveli.
The Company received Certificate of Commencement of Business, issued by Assistant Registrar of Companies, Gujarat, on November 20, 2003. The Company is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

About Rossari Biotech Ltd

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry.
It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals.
The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each.

FAQs for the comparison of Anupam Rasayan India Ltd and Rossari Biotech Ltd

Which company has a larger market capitalization, Anupam Rasayan India Ltd or Rossari Biotech Ltd?

Market cap of Anupam Rasayan India Ltd is 14,253 Cr while Market cap of Rossari Biotech Ltd is 2,270 Cr

What are the key factors driving the stock performance of Anupam Rasayan India Ltd and Rossari Biotech Ltd?

The stock performance of Anupam Rasayan India Ltd and Rossari Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anupam Rasayan India Ltd and Rossari Biotech Ltd?

As of March 22, 2026, the Anupam Rasayan India Ltd stock price is INR ₹1251.95. On the other hand, Rossari Biotech Ltd stock price is INR ₹410.0.

How do dividend payouts of Anupam Rasayan India Ltd and Rossari Biotech Ltd compare?

To compare the dividend payouts of Anupam Rasayan India Ltd and Rossari Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.